Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Short-Term Debt repayments (2017 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Short-Term Debt repayments for 6 consecutive years, with $26.5 million as the latest value for Q3 2025.

  • Quarterly Short-Term Debt repayments rose 2.71% to $26.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $105.5 million through Sep 2025, up 5.16% year-over-year, with the annual reading at $105.1 million for FY2024, 36.59% up from the prior year.
  • Short-Term Debt repayments for Q3 2025 was $26.5 million at Xtant Medical Holdings, up from $25.9 million in the prior quarter.
  • The five-year high for Short-Term Debt repayments was $27.5 million in Q2 2024, with the low at $12.3 million in Q1 2022.
  • Average Short-Term Debt repayments over 5 years is $20.1 million, with a median of $20.1 million recorded in 2023.
  • The sharpest move saw Short-Term Debt repayments dropped 6.36% in 2022, then soared 55.04% in 2024.
  • Over 5 years, Short-Term Debt repayments stood at $13.5 million in 2021, then increased by 10.6% to $14.9 million in 2022, then soared by 49.44% to $22.3 million in 2023, then increased by 21.75% to $27.1 million in 2024, then decreased by 2.33% to $26.5 million in 2025.
  • According to Business Quant data, Short-Term Debt repayments over the past three periods came in at $26.5 million, $25.9 million, and $26.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.